Compare BRAG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRAG | NEPH |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 45.3M |
| IPO Year | 2021 | 2004 |
| Metric | BRAG | NEPH |
|---|---|---|
| Price | $1.50 | $3.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 28.2K | ★ 37.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 106.67 |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $14,162,000.00 |
| Revenue This Year | $6.63 | $33.32 |
| Revenue Next Year | N/A | $12.27 |
| P/E Ratio | ★ N/A | $38.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.46 | $1.49 |
| 52 Week High | $4.82 | $6.42 |
| Indicator | BRAG | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 28.62 | 37.55 |
| Support Level | N/A | $3.32 |
| Resistance Level | $2.77 | $4.93 |
| Average True Range (ATR) | 0.12 | 0.24 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 17.31 | 2.86 |
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.